Use of RT-Defective HIV Virions: New Tool to Evaluate Specific Response in Chronic Asymptomatic HIV-Infected Individuals

• Alberto Crespo Guardo ,

  Contributed equally to this work with: Alberto Crespo Guardo, Carmen Álvarez-Fernández

  Affiliations Retrovirology and Viral Immunopathology Laboratory, Institut d´Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain, Catalan Program for HIV Vaccine Development (HIVACAT), Barcelona, Spain

  ⨯
• Carmen Álvarez-Fernández ,

  Contributed equally to this work with: Alberto Crespo Guardo, Carmen Álvarez-Fernández

  Affiliations Retrovirology and Viral Immunopathology Laboratory, Institut d´Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain, Catalan Program for HIV Vaccine Development (HIVACAT), Barcelona, Spain

  ⨯
• Hodei Arberas,

  Affiliations Retrovirology and Viral Immunopathology Laboratory, Institut d´Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain, Catalan Program for HIV Vaccine Development (HIVACAT), Barcelona, Spain

  ⨯
• Javier García-Pérez,

  Affiliation AIDS Immunopathology Unit. National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Felipe García,

  Affiliations Catalan Program for HIV Vaccine Development (HIVACAT), Barcelona, Spain, Infectious Diseases Unit, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain

  ⨯
• Manuel Enric Bargalló,

  Affiliations Retrovirology and Viral Immunopathology Laboratory, Institut d´Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain, Catalan Program for HIV Vaccine Development (HIVACAT), Barcelona, Spain

  ⨯
• María José Maleno,

  Affiliations Retrovirology and Viral Immunopathology Laboratory, Institut d´Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain, Catalan Program for HIV Vaccine Development (HIVACAT), Barcelona, Spain

  ⨯
• José María Gatell,

  Affiliations Catalan Program for HIV Vaccine Development (HIVACAT), Barcelona, Spain, Infectious Diseases Unit, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain

  ⨯
• Beatriz Mothe,

  Affiliation Institut de Recerca de la SIDA IrsiCaixa – HIVACAT, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

  ⨯
• José Alcami,

  Affiliation AIDS Immunopathology Unit. National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Sonsoles Sánchez-Palomino,

  Affiliations Retrovirology and Viral Immunopathology Laboratory, Institut d´Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain, Catalan Program for HIV Vaccine Development (HIVACAT), Barcelona, Spain

  ⨯
• Montserrat Plana

  * E-mail: mplana@clinic.ub.es

  Affiliations Retrovirology and Viral Immunopathology Laboratory, Institut d´Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain, Catalan Program for HIV Vaccine Development (HIVACAT), Barcelona, Spain

  ⨯